跳至主要内容
临床试验/NCT04055831
NCT04055831Unknown不适用

Immune Biomarkers Related to Bone Pathology in Patients With Type 1 Gaucher Disease

Lysosomal and Rare Disorders Research and Treatment Center, Inc.1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2019年5月15日最近更新:
适应症

试验速览

阶段
不适用
入组人数
40
试验地点
1
主要终点
Measure biomarkers level in molar/l/h

研究概览

简要总结

Bone-related problems represent the principal unmet medical need in Gaucher disease (GD). 75% of GD type 1 patients develop skeletal complications, including bone remodeling defects, osteopenia, osteoporosis, marrow infiltration, avascular necrosis, and osteolysis. However, the underlying cellular/molecular basis of bone involvement and related complications in GD are not fully known. Neither are there any bone-specific markers associated with individual bone pathology. Early diagnosis of bone disease is the key issue for planning individual therapy to prevent and reverse bone disease in GD.

详细描述

This clinical observational study is designed to identify specific biomarkers for bone involvement in patients with GD1 with decreased bone density and/or bone structural abnormalities

Aims:

  1. Identify novel immune cell surface and biochemical markers in peripheral blood correlating with bone involvement in GD.
  2. Assess the correlation between cytokine levels in peripheral blood and the severity of bone involvement in GD.
  3. Assess the relationship between glycosphingolipids accumulation and macrophage activation with specific bone markers and GD severity.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
16 Years 至 90 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • To be enrolled in this study the subject must meet the following criteria
  • Subject is greater than 16 years old but not older than 90 years
  • Signed Informed Consent/Assent
  • Subject is able and willing to sign informed consent or assent
  • If the subject has GD1, the must have a confirmed diagnosis of Gaucher disease by
  • GCase enzyme activity
  • DNA analysis demonstrating pathogenic variants in the GBA gene

排除标准

  • a) Have evidence of hepatitis B, hepatitis C infection or any other chronic infectious disease b) Be pregnant or breastfeeding

结局指标

主要结局

Measure biomarkers level in molar/l/h

时间窗: 18 months

Bone homeostasis is dependent on the balance of deposition by osteoblasts DMP-1, OSCAR, Calcitonin, Lyso-GB1, chitotriosidase, CCL18, osteocalcin, BALP, cathepsin K , TRAP 5, RANKL, OPG, DDK-1, sclerostin, MCP1, IL-2, IL-6, IL-10, SRTH2 and TNF-α

Measure biomarkers level: molar/mg/h

时间窗: 18 months

DMP-1, RANK, OSCAR, cathepsin K, OPG

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验